年龄与血管内治疗结局:韩台两国9934例登记研究
该研究整合韩国与台湾多中心前瞻性卒中登记,纳入2011至2023年9934例血管内治疗患者,比较两地患者特征与结局并分析年龄影响。台湾患者危险因素更多、卒中更重、3个月良好结局率更低;高龄与功能恢复较差相关,但症状性颅内出血风险未随年龄显著增加。
要点
- 台湾EVT患者较韩国患者危险因素更多、卒中更重、3个月良好结局率更低。
- 年龄增长与EVT后功能恢复较差相关,≥80岁患者仅18%达到mRS 0-2分。
- 症状性颅内出血风险未随年龄显著增加,高龄不应单独作为排除EVT的依据。
核心结论
- 高龄与EVT后功能恢复较差相关,但症状性颅内出血风险未随年龄显著增加。
- 经选择的老年患者,尤其卒中前功能独立或接受桥接溶栓者,仍可获益。
研究设计与样本
- 整合韩国CRCS-K与台湾TREAT-AIS两个多中心前瞻性卒中登记,形成9934例EVT统一数据集。
- 纳入2011至2023年EVT病例,韩国7835例、台湾2099例。
- 采用logistic回归模型分析年龄与结局关联,校正相关协变量。
主要发现
- 总体平均年龄70.1±12.9岁,男性57.6%,NIHSS中位数14(IQR 9-19)。
- 台湾患者较韩国患者危险因素患病率更高、卒中更严重,3个月良好结局率更低。
- ≥80岁患者中18%达到mRS 0-2分,年轻患者为46%。
- 症状性颅内出血风险未随年龄显著增加:每增1岁校正OR 1.01(0.99-1.02),≥80岁校正OR 0.98(0.75-1.29)。
- 卒中前功能独立、基线血红蛋白和桥接溶栓被识别为高龄患者结局的显著效应修饰因素。
关键数值与推荐
- 主要结局包括3个月改良Rankin量表(mRS)、症状性颅内出血和成功再通。
- ≥80岁患者18%达到mRS 0-2分,年轻患者为46%。
- 症状性颅内出血每增1岁校正OR 1.01(0.99-1.02),≥80岁校正OR 0.98(0.75-1.29)。
临床怎么用
- 高龄不应单独作为排除EVT的依据,应结合卒中前功能状态个体化决策。
- 对卒中前功能独立或接受桥接溶栓的高龄患者,EVT可能带来有意义的获益。
- 东亚人群EVT决策需考虑国家间危险因素谱和卒中严重度的差异。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As populations age, there is an increasing need to optimize endovascular treatment (EVT) and to understand country-specific differences in East Asia. We harmonized stroke registries from Korea and Taiwan to enable comparisons of patient characteristics and outcomes, with a particular focus on the impact of age. METHODS: Multicenter prospective stroke registries in Korea (CRCS-K [Clinical Research Collaboration for Stroke in Korea]) and Taiwan (TREAT-AIS [Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke]) were harmonized to form a unified data set of patients undergoing EVT. Outcomes included 3-month modified Rankin Scale, symptomatic intracranial hemorrhage, and successful recanalization. We assessed the association between age and outcomes in the overall population and those who were aged ≥80 years using logistic regression models, adjusting for relevant covariates. RESULTS: A total of 9934 EVT cases (7835 from Korea and 2099 from Taiwan) were included from 2011 to 2023. Patients had a mean age of 70.1±12.9 years (57.6% male; median National Institutes of Health Stroke Scale score, 14 [interquartile range, 9-19]). Compared with Korean patients, Taiwanese patients had a higher prevalence of risk factors and more severe strokes, contributing to lower rates of favorable 3-month outcomes. Increasing age was associated with poorer EVT results; among patients ≥80 years, 18% achieved a modified Rankin Scale score of 0 to 2, compared with 46% of younger patients. However, the risk of symptomatic intracranial hemorrhage did not significantly increase with age (adjusted odds ratio per year, 1.01 [0.99-1.02]; adjusted odds ratio of ≥80 years, 0.98 [0.75-1.29]). Prestroke functional independence, baseline hemoglobin, and bridging thrombolysis were identified as significant modifiers of outcomes in the oldest patients. CONCLUSIONS: Taiwanese EVT patients had more risk factors and worse outcomes than Korean patients. Advanced age is associated with poorer functional recovery, yet selected older patients, particularly those who were functionally independent before the stroke or received bridging thrombolysis, demonstrated meaningful benefit. These results underscore the importance of individualized treatment strategies and careful patient selection, especially as populations continue to age.
引用
- Kim BJ, Tang SC, Hsieh YC, et al. Association Between Age and Endovascular Treatment Outcomes: Binational Registry of 9934 EVT Cases From Korea and Taiwan. Stroke. 2025. PMID: 40620221. doi:10.1161/STROKEAHA.124.050483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。